SureTrader
Home > Boards > US Listed > Biotechs > ImmunoCellular Therapeutics, Ltd. (IMUC)

http://www.marketresearchhub.com/report/global-cell-therapy-market-2017-2021-report.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
PyschoNoobStock Member Profile
Member Level 
Followed By 103
Posts 12,763
Boards Moderated 3
Alias Born 04/12/12
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2018 6:33:07 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/13/2018 6:32:40 AM
ImmunoCellular Therapeutics Announces Update on Financial Condition PR Newswire (US) - 2/13/2018 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/2/2018 4:19:43 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/16/2018 12:48:08 PM
ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program PR Newswire (US) - 12/13/2017 4:05:00 PM
ImmuncoCellular Therapeutics to Present at the 10th Annual LD Micro Main Event on December 7, 2017 PR Newswire (US) - 11/22/2017 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/21/2017 4:22:57 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/21/2017 4:06:01 PM
ImmunoCellular Therapeutics Announces Third Quarter 2017 Financial Results PR Newswire (US) - 11/21/2017 4:05:00 PM
ImmunoCellular Therapeutics to Report Third Quarter 2017 Financial Results on November 21, 2017 PR Newswire (US) - 11/17/2017 6:00:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/15/2017 4:47:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/11/2017 8:32:29 AM
ImmunoCellular Therapeutics to Present at the Lytham Partners Virtual Investor Conference on October 11, 2017 at 2:00pm ET PR Newswire (US) - 10/3/2017 6:00:00 AM
ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its Plan of Compliance PR Newswire (US) - 9/13/2017 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/28/2017 4:32:17 PM
ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy PR Newswire (US) - 8/23/2017 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/17/2017 4:33:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/17/2017 4:18:12 PM
ImmunoCellular Therapeutics Announces Second Quarter 2017 Financial Results PR Newswire (US) - 8/14/2017 6:00:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2017 5:27:29 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/31/2017 6:09:24 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2017 4:32:22 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/21/2017 4:32:40 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 7/20/2017 4:13:04 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist